FI872517A0 - Förfarande för framställning av terapeutiskt användbara makrolidföreningar - Google Patents

Förfarande för framställning av terapeutiskt användbara makrolidföreningar

Info

Publication number
FI872517A0
FI872517A0 FI872517A FI872517A FI872517A0 FI 872517 A0 FI872517 A0 FI 872517A0 FI 872517 A FI872517 A FI 872517A FI 872517 A FI872517 A FI 872517A FI 872517 A0 FI872517 A0 FI 872517A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
macrolide compounds
useful macrolide
compounds
Prior art date
Application number
FI872517A
Other languages
English (en)
Finnish (fi)
Other versions
FI90663C (sv
FI872517A (sv
FI90663B (sv
Inventor
Derek R Sutherland
Michael V J Ramsay
Edward P Tiley
Oswy Z Pereira
John B Ward
Neil Porter
Hazel M Noble
Richard A Fletton
David Noble
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868613790A external-priority patent/GB8613790D0/en
Priority claimed from GB868625854A external-priority patent/GB8625854D0/en
Priority claimed from GB878708423A external-priority patent/GB8708423D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI872517A0 publication Critical patent/FI872517A0/sv
Publication of FI872517A publication Critical patent/FI872517A/sv
Priority to FI923445A priority Critical patent/FI90549C/sv
Application granted granted Critical
Publication of FI90663B publication Critical patent/FI90663B/sv
Publication of FI90663C publication Critical patent/FI90663C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N49/00—Biocides, pest repellants or attractants, or plant growth regulators, containing compounds containing the group, wherein m+n>=1, both X together may also mean —Y— or a direct carbon-to-carbon bond, and the carbon atoms marked with an asterisk are not part of any ring system other than that which may be formed by the atoms X, the carbon atoms in square brackets being part of any acyclic or cyclic structure, or the group, wherein A means a carbon atom or Y, n>=0, and not more than one of these carbon atoms being a member of the same ring system, e.g. juvenile insect hormones or mimics thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Insects & Arthropods (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI872517A 1986-06-06 1987-06-04 Förfarande för framställning av terapeutiskt användbara makrolidföreningar FI90663C (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI923445A FI90549C (sv) 1986-06-06 1992-07-30 Makrolidföreningar och användning av dem vid bekämpning av skadekryp

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB868613790A GB8613790D0 (en) 1986-06-06 1986-06-06 Chemical compounds
GB8613790 1986-06-06
GB8625854 1986-10-29
GB868625854A GB8625854D0 (en) 1986-10-29 1986-10-29 Chemical process
GB878708423A GB8708423D0 (en) 1987-04-08 1987-04-08 Chemical compounds
GB8708423 1987-04-08

Publications (4)

Publication Number Publication Date
FI872517A0 true FI872517A0 (sv) 1987-06-04
FI872517A FI872517A (sv) 1987-12-07
FI90663B FI90663B (sv) 1993-11-30
FI90663C FI90663C (sv) 1994-03-10

Family

ID=27263057

Family Applications (2)

Application Number Title Priority Date Filing Date
FI872517A FI90663C (sv) 1986-06-06 1987-06-04 Förfarande för framställning av terapeutiskt användbara makrolidföreningar
FI923445A FI90549C (sv) 1986-06-06 1992-07-30 Makrolidföreningar och användning av dem vid bekämpning av skadekryp

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI923445A FI90549C (sv) 1986-06-06 1992-07-30 Makrolidföreningar och användning av dem vid bekämpning av skadekryp

Country Status (35)

Country Link
US (1) US4900753A (sv)
JP (1) JP2648147B2 (sv)
KR (1) KR950010077B1 (sv)
CN (1) CN1023858C (sv)
AR (1) AR244691A1 (sv)
AT (1) AT398571B (sv)
AU (1) AU609399B2 (sv)
BE (1) BE1000201A4 (sv)
BR (1) BR8702866A (sv)
CA (1) CA1296329C (sv)
CH (1) CH677670A5 (sv)
DE (3) DE19875029I2 (sv)
DK (1) DK166498B1 (sv)
EG (1) EG18752A (sv)
ES (1) ES2006479A6 (sv)
FI (2) FI90663C (sv)
FR (1) FR2599742B1 (sv)
GB (1) GB2192630B (sv)
GE (1) GEP19981388B (sv)
GR (1) GR870891B (sv)
HU (1) HU199847B (sv)
IE (1) IE60411B1 (sv)
IL (1) IL82776A (sv)
IT (1) IT1206015B (sv)
LU (2) LU86908A1 (sv)
LV (2) LV10280A (sv)
NL (2) NL193376C (sv)
NZ (1) NZ220587A (sv)
OA (1) OA08606A (sv)
PH (1) PH23948A (sv)
PL (3) PL153036B1 (sv)
PT (1) PT85018B (sv)
SE (1) SE503399C2 (sv)
TR (1) TR28970A (sv)
UA (1) UA45300C2 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260537A1 (en) * 1986-09-12 1988-03-23 American Cyanamid Company 13-Deoxy-23-oxo(keto) and 23-imino derivatives of 13-deoxy C-076-aglycone compounds
ES2058082T3 (es) * 1986-09-12 1994-11-01 American Cyanamid Co Derivados 23-oxo (ceto) y 23-imino de compuestos ll-f28249.
US4886828A (en) * 1986-09-12 1989-12-12 American Cyanamid Company Δ22 -derivatives of LL-F28249 compounds
GB8721377D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical compounds
GB8811036D0 (en) * 1988-05-10 1988-06-15 Glaxo Group Ltd Chemical compounds
GB8813150D0 (en) * 1988-06-03 1988-07-06 American Cyanamid Co Chemical compounds
GB8905605D0 (en) * 1989-03-11 1989-04-26 Beecham Group Plc Novel compounds
NZ233680A (en) * 1989-05-17 1995-02-24 Beecham Group Plc Avermectins and milbemycins and compositions thereof
US4988824A (en) * 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds
CA2097918C (en) * 1990-12-07 2002-07-16 Frank N. Chang Stabilized insect nematode compositions
JP2855181B2 (ja) 1993-12-10 1999-02-10 敏雄 鈴木 松類の枯損防止用組成物及び防止方法
DK1197215T3 (da) 2000-10-10 2006-07-10 Wyeth Corp Anthelmintiske sammensætninger
US7348417B2 (en) * 2003-08-07 2008-03-25 Wyeth Method of purifying moxidectin through crystallization
WO2006119174A1 (en) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
JP4939025B2 (ja) * 2005-09-30 2012-05-23 三菱電線工業株式会社 電熱ヒータ付きハンドル用グリップ部材
EP1849363A1 (en) * 2006-03-09 2007-10-31 Cheminova A/S Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
DK3351546T5 (da) 2011-12-02 2024-08-12 Boehringer Ingelheim Vetmedica Gmbh Langtidsvirkende injicerbare moxidectinformuleringer
FR2995605B1 (fr) * 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH15982A (en) * 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4289760A (en) * 1980-05-02 1981-09-15 Merck & Co., Inc. 23-Keto derivatives of C-076 compounds
US4423209A (en) * 1982-02-26 1983-12-27 Merck & Co., Inc. Processes for the interconversion of avermectin compounds
JPS59108785A (ja) * 1982-11-25 1984-06-23 Sankyo Co Ltd ミルベマイシン類の５−オキシム誘導体
JPS60126289A (ja) * 1983-11-14 1985-07-05 Sankyo Co Ltd ミルベマイシン類の５−カ−ボネ−ト誘導体
EP0170006B1 (en) * 1984-06-05 1992-07-08 American Cyanamid Company Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
US4579864A (en) * 1984-06-11 1986-04-01 Merck & Co., Inc. Avermectin and milbemycin 13-keto, 13-imino and 13-amino derivatives
IT1182857B (it) * 1984-09-14 1987-10-05 Glaxo Group Ltd Composti antibiotici, composizioni antiparassitarie che li contengono e procedimento per prepararli ed applicarli
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
ES2058082T3 (es) * 1986-09-12 1994-11-01 American Cyanamid Co Derivados 23-oxo (ceto) y 23-imino de compuestos ll-f28249.

Also Published As

Publication number Publication date
CA1296329C (en) 1992-02-25
FI923445A0 (sv) 1992-07-30
EG18752A (en) 1993-12-30
GB8713239D0 (en) 1987-07-08
NL8701322A (nl) 1988-01-04
LU86908A1 (fr) 1988-01-20
LV10781B (en) 1996-10-20
GEP19981388B (en) 1998-11-10
IL82776A (en) 1992-02-16
KR880000441A (ko) 1988-03-25
NL990026I1 (nl) 1999-11-01
NL193376C (nl) 1999-08-03
GB2192630A (en) 1988-01-20
JP2648147B2 (ja) 1997-08-27
SE8702361L (sv) 1987-12-07
DK290287A (da) 1987-12-07
FI923445A (sv) 1992-07-30
SE503399C2 (sv) 1996-06-10
IT1206015B (it) 1989-04-05
SE8702361D0 (sv) 1987-06-05
NZ220587A (en) 1990-05-28
FR2599742B1 (fr) 1989-05-19
PH23948A (en) 1990-01-23
IL82776A0 (en) 1987-12-20
IE871496L (en) 1987-12-06
AU7387387A (en) 1987-12-10
GR870891B (en) 1987-10-02
AR244691A1 (es) 1993-11-30
PL266100A1 (en) 1988-07-21
FI90663C (sv) 1994-03-10
OA08606A (en) 1988-11-30
KR950010077B1 (ko) 1995-09-06
LV10280A (lv) 1994-10-20
DK290287D0 (da) 1987-06-04
BR8702866A (pt) 1988-03-01
FI90549C (sv) 1994-02-25
PT85018A (en) 1987-07-01
CN87104431A (zh) 1987-12-30
UA45300C2 (uk) 2002-04-15
LV10781A (lv) 1995-08-20
AT398571B (de) 1994-12-27
DK166498B1 (da) 1993-06-01
GB2192630B (en) 1990-05-23
ES2006479A6 (es) 1989-05-01
NL193376B (nl) 1999-04-01
DE3745133C2 (de) 1998-01-02
AU609399B2 (en) 1991-05-02
DE3718926A1 (de) 1987-12-10
CH677670A5 (sv) 1991-06-14
FI872517A (sv) 1987-12-07
LU88790I2 (fr) 1997-03-18
FI90549B (sv) 1993-11-15
HU199847B (en) 1990-03-28
ATA143887A (de) 1994-05-15
DE19875029I2 (de) 2001-11-22
DE3718926C2 (de) 1998-01-15
NL990026I2 (nl) 1999-12-01
TR28970A (tr) 1997-07-21
CN1023858C (zh) 1994-02-23
FI90663B (sv) 1993-11-30
HUT44254A (en) 1988-02-29
FR2599742A1 (fr) 1987-12-11
PL155723B1 (en) 1991-12-31
IT8748023A0 (it) 1987-06-05
PL153226B1 (en) 1991-03-29
PT85018B (pt) 1990-03-08
US4900753A (en) 1990-02-13
BE1000201A4 (fr) 1988-08-23
JPS6354375A (ja) 1988-03-08
PL153036B1 (en) 1991-02-28
IE60411B1 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
PT86934A (pt) Process for the preparation of a thiazepine compound
FI104170B1 (sv) Förfarande för framställning av terapeutiskt användning 3-aminopyrazolderivat
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
FI874459A (sv) Förfarande för framställning av terapeutiskt användbara piperidinderivat
PT86800A (pt) Process for the preparation of erythromycin derivatives
FI872517A0 (sv) Förfarande för framställning av terapeutiskt användbara makrolidföreningar
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
FI94250B (sv) Förfarande för framställning av nya, terapeutiskt användbara etrar
PT87191A (pt) Process for the preparation of nucleosides
FI92696C (sv) Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat
FI90877C (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI883672A (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI895393A0 (sv) Förfarande för framställning av terapeutiskt användbara alkylsubstituerade-2-alkylaminbensopyran-6-oler
FI883889A0 (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI873350A0 (sv) Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
PT87065A (pt) Process for the preparation of a vaccine against pasteurellosis
FI893936A0 (sv) Förfarande för framställning av terapeutiskt aktiva föreningar samt mellanprodukter
FI893003A (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI92064C (sv) Förfarande för framställning av terapeutiskt användbara N-bensopyranyllaktamer
FI911420A0 (sv) Förfarande för framställning av terapeutiskt användbara föreningar
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI884473A (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
PT86938A (pt) Process for the preparation of a macrocyclic compound
FI892420A (sv) Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat

Legal Events

Date Code Title Description
BB Publication of examined application
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L124

Extension date: 20091229

FG Patent granted

Owner name: WYETH HOLDINGS CORPORATION

MA Patent expired